Skip to main content
. 2012 Jun 28;16(7):1629–1639. doi: 10.1111/j.1582-4934.2011.01406.x

Fig 6.

Fig 6

Evaluation of the effects of AG30/5C in a diabetic mouse wound-healing model with or without MRSA infection. (A) Time course of the quantification of wound size in diabetic mice with treatment of saline (control), AG30/5C or LL37 (100 μg/ml, respectively). N = 6–10 per group and duplicated. *P < 0.05 versus AG30/5C, †P < 0.05 versus LL37. (B, C) Evaluation of infectious wound healing in a diabetic mouse model treated with saline (control), modified AG30 or LL37. (B) Representative pictures of infectious wounds at days 2, 9 and 14. (C) Time course of the quantification of infectious wound size in diabetic mice treated with saline (control), AG30/5C or LL37 (100 μg/ml, respectively). N = 5–9 per group and duplicated. *P < 0.05 versus AG30/5C, †P < 0.05 versus LL37.